G. Quintero-Aldana

Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study

J. Feliu, B. Massuti, M. Valladares-Ayerbes, 2021, Cancer Chemotherapy and Pharmacology.

FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial

F. Rivera, R. García-Carbonero, E. Díaz-Rubio, 2020, ESMO Open.

Neo‐adjuvant treatment of infiltrating transitional‐cell carcinoma of the bladder with paclitaxel and cisplatin: A phase II trial

M. Rico, J. Mel, S. Vázquez, 2002, International journal of urology : official journal of the Japanese Urological Association.

Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer

E. Gallardo, M. Salgado, R. López, 2015, Cancer Chemotherapy and Pharmacology.

Cetuximab Given Every 2 Weeks plus Irinotecan Is an Active and Safe Option for Previously Treated Patients with Metastatic Colorectal Cancer

Cristina Martín, C. Pericay, C. Grande, 2010, Chemotherapy.